Phase Ii Study Of Copanlisib In Patients With Tumors With Pik3ca Mutations (Pten Loss Allowed): Nci Match Eay131-Z1f.
Senthil Damodaran,Fengmin Zhao,Dustin A. Deming,Edith P. Mitchell,John Joseph Wright,Laurence A Doyle,Robert James Gray,Shuli Li,Lisa McShane,Larry V Rubinstein,David R Patton,Mickey Williams,Stanley R. Hamilton, Jennifer Marie Suga,Barbara A. Conley,Carlos L. Arteaga,Lyndsay Harris,Peter J. O'Dwyer,Alice P. Chen,Keith Flaherty JOURNAL OF CLINICAL ONCOLOGY（2020）
AI 理解论文
溯源树
样例
